Skip to main content

Samanes Agreda, Gloria

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Samanes Agreda, Gloria

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Maria Elena Ballarin Alins

Maria Elena Ballarin Alins

Research assistant
Clinical Pharmacology
Read more
Micaela Cecilia Abud

Micaela Cecilia Abud

Gestió i Administració
Infrastructure Coordination
Manager
Read more
Felipe Andres Grunenwald Bravo

Felipe Andres Grunenwald Bravo

Postdoctoral researcher
Neurodegenerative Diseases
Read more
Amparo García Burillo

Amparo García Burillo

Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.